Skip to navigation
Skip to content
Urgostart.Com
Urgostart.Com
Navigation
2:
WOUNDS
2.1:
Wound healing
2.2:
Biochemistry
2.4:
Wound treatment
3:
URGOCELL START CONTACT
3.1:
Presentation
3.2:
Mode of action
3.3:
Benefits
3.4:
In practice
3.5:
Clinical evidence
3.6:
Posters
3.7:
FAQ
4:
OTHER START PRODUCTS
4.1:
Urgotul Start
4.2:
Ktwo start
5:
TESTIMONIAL
Choose your country
Global
Deutschland
France
United-Kingdom
Home
Contact
www.urgo.com
www.urgomedical.com
3.1:
Presentation
3.2:
Mode of action
3.3:
Benefits
3.4:
In practice
3.5:
Clinical evidence
3.6:
Posters
3.7:
FAQ
Posters EWMA 2009
Click on picture to see the document (pdf)
Benefit of the NOSF absorbent lipido-colloid dressing in the treatmentof arterial ulcers that are stagnant despite a revascularisation procedure
Benefit of the NOSF absorbent lipido-colloid dressing in the treatment of perforating ulcers of the foot
Local treatment of delayed healing wounds in the wound healing unit
Experience of the NOSF absorbent lipido-colloid dressings in the local management of pressure ulcers
Local treatment of pressure ulcers in a specialist centre for multiple sclerosis patients: experience with the NOSF absorbent lipido-colloid dressing
NOSF absorbent lipido-colloid dressing - Results of an observational study in Germany
Management of delayed healing post-traumatic wounds that have become chronic
Treatment of delayed healing wounds following a surgical procedure in a plastic and reconstructive surgery department
Effect of Nano-Oligosaccharide factor (NOSF) on endothelial cell activity in vitro
Effect of the new lipido-colloid micro-adherent absorbent dressing on fibroblast proliferation in vitro
Benefit of the new NOSF absorbent lipido-colloid dressing in the management of chronic skin ulcerations with a delayed healing prognosis
Leg ulcers and the new micro-adherent absorbent dressing - Results of the clinical qualification study
Observation of the new lipido-colloid contact layer in the local management of acute and chronic wounds